Form 8-K - Current report:
SEC Accession No. 0000950170-25-052527
Filing Date
2025-04-09
Accepted
2025-04-09 16:21:30
Documents
16
Period of Report
2025-04-07
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rani-20250407.htm   iXBRL 8-K 49928
2 EX-16.1 rani-ex16_1.htm EX-16.1 10329
3 GRAPHIC img163111488_0.jpg GRAPHIC 25972
4 GRAPHIC img163111488_1.jpg GRAPHIC 3078
5 GRAPHIC img163111488_2.jpg GRAPHIC 895
6 GRAPHIC img163111488_3.jpg GRAPHIC 895
  Complete submission text file 0000950170-25-052527.txt   223781

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rani-20250407.xsd EX-101.SCH 26034
18 EXTRACTED XBRL INSTANCE DOCUMENT rani-20250407_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 25825482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)